Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/33039
Title: | Evaluating the Effectiveness of a Novel Skin Barrier Protectant in a Patient with Acute Radiodermatitis of the Vulva: A Case Report | Authors: | Van Bever, Leen Claes, Stefan ROBIJNS, Jolien Censabella, Sandrine Pannekoeke, Luc Van de Werf, Evelyn BULENS, Paul |
Issue Date: | 2020 | Publisher: | Source: | Advances in Skin & Wound Care, 34 (1) , p. 49 -55 | Abstract: | Objective To evaluate the use of Cavilon Advanced Skin Protectant in a patient treated with radiotherapy for vulvar cancer. Design Case report study Setting Radiotherapy department Participants Two female patients undergoing radiotherapy for vulvar carcinoma. Interventions In this case report study a novel skin barrier protectant, Cavilon Advanced Skin Protectant, was evaluated in a patient treated with vulvar radiodermatitis. Besides, another patient with vulvar radiodermatitis undergoing the institutional standard skin care protocol was portrayed. Main Outcome Measures Patient's skin reactions were evaluated by using the Radiotherapy Oncology Group Criteria by a radiotherapy nurse, alongside the patient's pain. | Keywords: | case report;radiation dermatitis;radiotherapy;skin barrier protectant;toxicity;vulvar carcinoma | Document URI: | http://hdl.handle.net/1942/33039 | ISSN: | 1527-7941 | e-ISSN: | 1538-8654 | DOI: | 10.1097/01.ASW.0000722768.95461.82 | ISI #: | 000600760600009 | Rights: | 2020 Wolters Kluwer Health, Inc. All rights reserved. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MainTextfile_casereport_270120_adv.pdf | Peer-reviewed author version | 183.27 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
1
checked on Jun 9, 2024
Page view(s)
14,858
checked on Sep 6, 2022
Download(s)
758
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.